OPRX Insider Trading Activity and SEC Form 4 Filings
OPRX insider trading summary
Over the past 12 months, insiders at OptimizeRx Corp (OPRX) reported 1 sale worth $19K by 1 insider and no open-market purchases on SEC Form 4. Net insider selling was $19K.
Latest OPRX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 19, 2025 | Edward Stelmakh | Chief Finance & Strat Officer | Sell | $19K (1,388 @ $13.51) |
| Oct 3, 2025 | Stephen L Silvestro | Chief Executive Officer | Sell | $30K (1,620 @ $18.75) |
| Aug 28, 2025 | Patrick D Spangler | Director | Sell | $194K (11,120 @ $17.49) |
| Mar 14, 2025 | James Paul Lang | Director | Buy | $2.4M (321,408 @ $7.60) |
| Dec 12, 2024 | William J Febbo | CEO | Buy | $100K (20,000 @ $5.01) |
| Jan 9, 2024 | Marion Odence-Ford | General Counsel and CCO | Sell | $61K (4,000 @ $15.19) |
| Aug 26, 2022 | Marion Odence-Ford | General Counsel and CCO | Buy | $16K (1,000 @ $15.75) |
| Aug 22, 2022 | William J Febbo | CEO | Buy | $164K (10,700 @ $15.29) |
| Aug 19, 2022 | James Paul Lang | Director | Buy | $99K (6,000 @ $16.45) |
| Aug 19, 2022 | William J Febbo | CEO | Buy | $87K (5,400 @ $16.18) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.